Scaling EV Isolation for the Clinic: Customised Workflows for EV Therapeutics and EV Diagnostics

Поділитися
Вставка
  • Опубліковано 21 лип 2024
  • Meet Izon Science's solutions to scaling extracellular vesicle (EV) isolation for clinical applications. Here we discuss the unique challenges of EV therapeutics and EV diagnostics, and introduce qEV PurePath: customisable workflow solutions designed for both fields. Learn how we handle large EV-containing sample volumes for EV therapeutics and ensure speed, cost-effectiveness, and high purity for EV diagnostics. With qEV PurePath, you can partner with us to transform crude samples to clinic-ready isolates, making your path to market smoother. Learn more here:
    qEV Purepath for Therapeutics:
    www.izon.com/qev/purepath-for...
    qEV PurePath for Diagnostics:
    www.izon.com/qev/qev-purepath...
    00:00 - Introduction
    00:31 - The challenges of bringing an extracellular vesicle-based product to market.
    01:31 - The differing needs of EV therapeutics and EV diagnostics development
    03:04 - qEV PurePath for EV Therapeutics
    08:06 - qEV PurePath for EV Diagnostics
  • Наука та технологія

КОМЕНТАРІ •